Stromal Fibroblasts Counteract the Caveolin-1-Dependent Radiation Response of LNCaP Prostate Carcinoma Cells.

Wittka, Alina; Ketteler, Julia; Borgards, Lars; Maier, Patrick; Herskind, Carsten; Jendrossek, Verena; Klein, Diana

Wittka, Alina; Ketteler, Julia; Borgards, Lars; Maier, Patrick; Herskind, Carsten; Jendrossek, Verena; Klein, Diana.

Afiliação

Wittka A; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical Faculty Essen, Essen, Germany.
Ketteler J; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical Faculty Essen, Essen, Germany.
Borgards L; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical Faculty Essen, Essen, Germany.
Maier P; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Herskind C; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Jendrossek V; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical Faculty Essen, Essen, Germany.
Klein D; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical Faculty Essen, Essen, Germany.

Front Oncol ; 12: 802482, 2022.

Article em En | MEDLINE | ID: mdl-35155239

Palavras-chave

SRC; caveolin-1; dasatinib; fibroblast; prostate cancer; radiotherapy; therapy resistance; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google